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Marı´a Concepcion Gil-Rodrı´guez,3,8 Dinah Clark,1 Hakon Hakonarson,1,2,9 Sara Halbach,10
Laura Daniela Michelis,1 Abhinav Rampuria,1 Eva Rossier,11 Stephanie Spranger,12
Lionel Van Maldergem,13 Sally Ann Lynch,14 Gabriele Gillessen-Kaesbach,3 Hermann-Josef Lu¨decke,15
Robert G. Ramsay,6,16 Michael J. McKay,17,18 Ian D. Krantz,1,2 Huiling Xu,6,16 Julia A. Horsfield,4
and Frank J. Kaiser3,*
The evolutionarily conserved cohesin complex was originally described for its role in regulating sister-chromatid cohesion during
mitosis and meiosis. Cohesin and its regulatory proteins have been implicated in several human developmental disorders, including
Cornelia de Lange (CdLS) and Roberts syndromes. Here we show that human mutations in the integral cohesin structural protein
RAD21 result in a congenital phenotype consistent with a ‘‘cohesinopathy.’’ Children with RAD21 mutations display growth retarda-
tion, minor skeletal anomalies, and facial features that overlap findings in individuals with CdLS. Notably, unlike children with
mutations in NIPBL, SMC1A, or SMC3, these individuals have muchmilder cognitive impairment than those with classical CdLS. Mech-
anistically, these mutations act at the RAD21 interface with the other cohesin proteins STAG2 and SMC1A, impair cellular DNA damage
response, and disrupt transcription in a zebrafish model. Our data suggest that, compared to loss-of-function mutations, dominant
missense mutations result in more severe functional defects and cause worse structural and cognitive clinical findings. These results
underscore the essential role of RAD21 in eukaryotes and emphasize the need for further understanding of the role of cohesin in human
development.Introduction
In eukaryotic cells, sister chromatids remain physically
connected from replication until their separation during
anaphase. This phenomenon, called sister-chromatid
cohesion, is essential for the proper segregation of the
duplicated genome. Sister-chromatid cohesion is mediated
by cohesin, a multimeric complex that consists of at least
four core proteins: a heterodimer of SMC1 and SMC3
that forms a hinged ring-like structure, plus two ‘‘clasp’’
proteins, STAG (stromal antigen, or Stromalin, also known
as SA) and RAD21, that play a central structural role.1 A
number of regulatory proteins, including NIPBL and
ESCO2, have also been found to have roles in cohesin’s
function.2–4 In addition to regulating sister-chromatid
cohesion, the cohesin complex has been implicated in
global transcriptional regulation5–10 and DNA double-
strand break (DSB) repair.11–15
Mutations in NIPBL (MIM 608667) have been identified
in ~60% of individuals with classical Cornelia de Lange
syndrome (CdLS [MIM 122470]), also termed Brach-
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including synophrys, arched eyebrows, a short anteverted
nose, micrognathia, hirsutism, upper-extremity abnormal-
ities ranging from small hands to severe deficiencies of the
limbs, cardiac defects, growth retardation, and moderate
to severe neurodevelopmental delay.16,17 Subsequently,
mutations in SMC1A18,19 (MIM 300040) and SMC319 (MIM
606062)were identified in ~5%of childrenwithmilder vari-
ants of CdLS; these children demonstrate fuller eyebrows,
a prominence of the nasal bridge, predominant cognitive
involvement, and few structural anomalies.20 In addition,
mutations in the gene encoding cohesin-regulatory protein
ESCO2 (MIM 609353) cause Roberts Syndrome and SC
Phocomelia21,22 (RS/SCP [MIM268300]), recessive disorders
that, like CdLS, involve growth failure and mental retarda-
tion, although the facial features and limb anomalies are
distinct from characteristics of CdLS.
The RAD21 subunit of the cohesin complex plays impor-
tant structural and functional roles, in that it serves as the
only physical link between the SMC1/SMC3 heterodimer
and the STAG subunit and that its integrity regulates the
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chromatin.1 Although human RAD21 (MIM 606462) was
initially cloned in 1996,23 in this work we identify
RAD21 mutations that cause an additional clinically over-
lapping disorder of cohesin. These findings thus expand
our understanding of the pervasive roles of the cohesin
complex in human development.Subjects and Methods
Human Subjects
All individuals were enrolled in the study under an Institutional
Review Board-approved protocol of informed consent at The Chil-
dren’s Hospital of Philadelphia, the Institut fu¨r Humangenetik
Lu¨beck, or the Institut fu¨r Humangenetik Essen.
Genome-wide Copy-Number Analysis
Whole-genome SNP genotyping was performed with Illumina
(San Diego, CA) Infinium HumanHap550 Beadchip or Affymetrix
(Fremont, CA) Genome-Wide Human SNP 6.0 arrays according to
the manufacturers’ protocols. Copy-number calling was per-
formed with custom algorithms24 and PennCNV.25 Inspection of
copy-number variants was performed for 8q24 by analysis of allele
frequency and log R ratios with Illumina BeadStudio (ver. 3.1.3) or
Affymetrix Chromosome Analysis Suite (version 1.0) software as
described.26
Mutation Identification
Genomic DNA was screened for mutations in the coding exons
and intron-exon boundaries by PCR of genomic DNA followed
by high-resolution melt-curve analysis27 and sequencing. Primers
were designed with ExonPrimer. Primer sequences and PCR condi-
tions for RAD21 are available upon request. Amplimers were
analyzed in duplicate with a LightScanner (Idaho Technology,
Salt Lake City, Utah). Any variants identified by high-resolution
melt-curve analysis were subsequently sequenced. Sequencing
was performed with BigDye Terminator v3.1 cycle sequencing
and analyzed on an ABI 3730 (Applied Biosystems, Carlsbad,
CA). All probands were pre-screened and found to be negative
for mutations in NIPBL, SMC1A, and SMC3. Sequence analysis
was performed with Sequence Pilot (JSI Medical Systems, Kippen-
heim, Germany), Sequencher v4.8 (Gene Codes Corporation, Ann
Arbor, MI) and MacVector v10.5.1 (Accelrys Corp, San Diego, CA).
Reference Sequences and RAD21 Conservation
Analysis
RefSeq ID numbers for mRNAs and proteins are as follows: human
RAD21 (NM_006265.2); human RAD21 (EAW91965); mouse
Rad21 (AF332086_1); Xenopus laevis rad21 (AAC26809); zebrafish
Rad21 (NP_955889); Drosophila melanogaster Rad21 (EAA46289);
C. elegans SCC-1 (NP_494836); and Saccharomyces cerevisiae Scc1
(NP_011321). Sequences were aligned by the ClustalW method28
with MacVector software (Accelrys Corp, San Diego, CA).
Modeling of the p.Cys585Arg Mutation on RAD21-
SMC1 Interaction
Awild-typemodel (wt) and p.Cys585Arg (c.1753T>C)model (mut)
of human RAD21 in complex with human SMC1Awere built with
the YASARA v10.8.16 software package.29,30 For the homology
models, running PSI-BLAST against UniProt generated a position-The Americspecific scoring matrix (PSSM). The PSSM was used in a Protein
Data Bank search for potential modeling templates. The templates
were ranked by an alignment score and WHAT_CHECK.31 The
highest-scoring template for human RAD21 complexed with
human SMC1A was the X-ray structure of the yeast SCC1-
SMC1complex32 (PDB code 1W1W). It was used for creating the
3D structure of the wt and mut models with default settings. A
hybrid model derived from 20 initial models was used for further
analysis. All models were energy minimized by a YAMBER3 force
field so that bumps were removed, and the covalent geometry
was corrected.33,34 After removal of conformational stress by
a short, steep descent minimization, the procedure continued by
simulated annealing until convergence was reached. After valida-
tion with WHAT_CHECK, the average-quality Z score for the wt
and mut models was 1.4, which is better than that for the
template (2.1). A structure file of the models and alignments is
available upon request.
After homology modeling, a molecular dynamics (MD) simula-
tion was performed on the wt and mut human RAD21-SMC1A
complexes. At first, a cubic cell was created around the atoms of
the homology model and was filled with water to a density of
0.997 g/liter. Counter ions were placed, and minimizations, first
with the water solvent and then with the whole system, were
done. After this, a short equilibration procedure calibrated the
models to 298K. Resulting models were used for a 4 ns MD simu-
lation (time step 2.5 fs).Tissue Culture
Lymphoblastoid cell lines (LCLs) were cultured in RPMI 1640
medium supplemented to 20% fetal bovine serum (FBS) and 2%
20mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml strep-
tomycin at 37C in 5% CO2. HeLa cells were cultured at 37C and
5% CO2 in DMEM supplemented to 10% FBS. Nonsense-mediated
decay was inhibited with 1 mg/ml cycloheximide (Sigma-Aldrich,
St. Louis, MO) in culture media for 6 hr prior to RNA harvesting.RT-PCR
LCLs were lysed and RNAwas harvested with RNeasy Plus Mini Kit
(QIAGEN, Valencia, CA). cDNA was synthesized with the Super-
Script III First-Strand Synthesis System (Invitrogen, Carlsbad,
CA) and random hexamers. TaqMan qRT-PCR gene-expression
assays were performed on the SDS-7900HTsystem (Applied Biosys-
tems, Carlsbad, CA. Samples were run in triplicate for RAD21 (ABI
Hs01085854_mH) and normalized to endogenous MAPK1 (ABI
Hs01052196_m1) levels.6 Analysis was performed with RQ
Manager 2.0 software (Applied Biosystems).Immunoblotting
Cells were lysed in a Nonidet P-40 lysis buffer (0.15M NaCl, 1%
NP-40, and 0.05M Tris-HCl [pH 8.0]) treated with a mixture of
protease inhibitors (0.25 mM PMSF, 10 mg/ml aprotinin and leu-
peptin, and 1mM DTT). Protein was separated via 7.5% SDS-
PAGE and transferred to a nitrocellulose membrane (Whatman,
London, UK). Membranes were incubated with a 1:200 dilution
of anti-Rad21 (Abcam, Cambridge, UK), a 1:500 dilution of anti-
GAL4-DBD/AD (Santa Cruz), or a 1:250 dilution of anti-actin
(Sigma) in 5% BLOTTO overnight at 4C. Secondary antibody
exposure was performed for 1 hr with 1:2000 anti-rabbit HRP
(Amersham Biosciences). Blots were visualized with the ECL
Western Blotting Analysis System (GE Healthcare). Quantitativean Journal of Human Genetics 90, 1014–1027, June 8, 2012 1015
chemiluminescent analysis was performed with a VersaDoc 5000
(Bio-Rad Laboratories, Philadelphia, PA).
Constructs
The human RAD21 (IMAGE 6044010; GenBank BC050381) and
zebrafish rad21 (NM_199595) open-reading frames, with the addi-
tion of BglII and XhoI sites, were amplified by PCR. They were
subsequently digested and ligated into BamHI- and XhoI-digested
pCS2þ.35,36 Mutations were introduced with the QuikChange
Site-Directed Mutagenesis Kit (Stratagene/Agilent, Santa Clara,
CA). Oligonucleotide sequences used are listed in Table S5.
Mammalian Two-Hybrid Quantitative Reporter
Assays
The full-length open-reading frame of human RAD21 was inserted
into the pCMV-BD expression plasmid (Stratagene, La Jolla, CA).
Mutant constructs were generated by site-directed in vitro muta-
genesis as above. The full-length open-reading frames of STAG1,
STAG2 and STAG3 (accession numbers BC064699, BX640970,
and BC047490, respectively) were cloned in-frame into the
pCMV-AD plasmid. HeLa cells were transiently transfected in
24-well plates (Sarstedt, Nu¨mbrecht, Germany) with FuGene-HD
(Roche, Mannheim, Germany) according to the manufacturer’s
instructions, and the expression of fusion proteins was verified
by immunoblotting. The phRG-TK Renilla expression vector
(Promega, Mannheim, Germany) was used as a transfection
control. After incubations of 24 hr, the activities of firefly and Re-
nilla luciferase were measured with the Dual Luciferase Reporter
Assay System (Promega) in a Berthold Luminometer (Berthold,
Bad Wildbad, Germany). All measurements were performed in at
least six independent experiments in triplicate. Relative luciferase
activity was determined as the average firefly:renilla luciferase
activity ratio.
Cell-Survival Assays
LCLs from affected individuals and controls were irradiated on ice
with graded doses of gamma radiation (0, 1, 2, 3, 4, and 5 Gy) from
a 137Cs source at a dose rate of 0.56 Gy per minute. Cells
were cultured for 96 hr, and cell viability was determined with
a tetrazolinium salt WST-1 [2-(4-Iodophenyl)-3-(4-nitrophenyl)-
5-(2,4-disulfophenyl)-2H-tetrazolium] (Roche Applied Science,
Indianapolis, IN) according to the manufacturer’s instructions.
WST-1 accumulates in proportion to mitochondrial density and
therefore is an indirect measure of cell number. The fraction of
cell survival was expressed as a ratio of surviving cells to unirradi-
ated cells (0 Gy). Each data point represents themean of four repli-
cates. Three independent experiments were performed for each
assay. Survival curves were fitted by nonlinear regression analysis
with the exponential model (Prism version 5.01, GraphPad Soft-
ware, San Diego, California USA).
Micronucleus Assays
The cytokinesis-block micronucleus assay was performed essen-
tially as described elsewhere.37 In brief, LCLs were subjected to
5 Gy of gamma radiation as described above. Cells were placed
at 37C for 4 hr to allow recovery. Unirradiated cells were used
as controls for spontaneous micronucleus frequencies. Cytocha-
lasin-B (Sigma-Aldrich, St. Louis, MO) was added at a final concen-
tration of 2 mg/ml so that cells that had undergone a single
karyokinesis but not cytokinesis could be identified; i.e., micronu-
clei from previous cell-cycle transits were excluded. Cells were1016 The American Journal of Human Genetics 90, 1014–1027, Juneharvested 44 hr after the addition of Cytochalasin-B, fixed in three
parts methanol:one part acetic acid, and dropped onto poly-L
slides. Slides were air-dried for 10 min and stained with Diff-Quick
(Lab Aids Pty Ltd, North Narrabeen, NSW, Australia). Slides were
scored for the number of binucleated cells (BNCs) containing (1)
micronuclei (MNi), (2) nucleoplasmic bridges (NPBs), and (3)
both MNi and NPBs according to described criteria.38 Two
hundred BNCs were scored for each cell line.Single-Cell Gel Electrophoresis, or Comet Assays
This assay quantifies DNA fragmentation as a result of DNA DSBs,
the main ionizing radiation (IR)-induced lesion correlating with
cell death. LCLs were irradiated on ice with 8 Gy of gamma irradi-
ation as above. Cells were harvested 0, ,1 and 4 hr after irradiation.
Unirradiated cells were used as a control for the basal level of DNA
damage. The comet assay for the detection of DSBs was performed
essentially as described.39 In brief, cell lysis was performed in
neutral lysis buffer (2M NaCl, 30 mM Na2EDTA, 10 mM Tris-
HCl, 1% Sarkosyl, 1% Triton X-100, and 10% DMSO [pH 8.3]),
and electrophoresis was carried out in TBE buffer (2 mMNa2EDTA,
90mMTris-HCl and 90mMBoric acid [pH 8.3]). DNA damage was
measured as the tail moment (tail moment ¼ [(tail length 3 tail
DNA intensity)/entire cell DNA intensity (head and tail)] 3 100)
with CASP image analysis software (http://casp.sourceforge.net).
For each data point, eight to ten images were captured. Tail
moments were measured for all cells, and doublets in each image
were excluded. The mean of tail moment was calculated with
a minimum of 50 cells per data point.Sister-Chromatid-Cohesion Assays
Metaphase spreads were performed on LCLs. Sister-chromatid
cohesionwas evaluated in two independent laboratories via a semi-
quantitative method where cells were arrested in 0.15 mg/ml
Colcemid (Sigma-Aldrich, St. Louis, MO) for 2 hr at 37C. After
a wash in PBS, cells were incubated in 1 ml 0.075M KCl hypotonic
buffer for 10 min. Cells were then fixed in three parts methano-
l:one part acetic acid and dropped onto Poly-L slides. Slides were
air dried and stained with Diff-Quick (Lab Aids Pty Ltd, North Nar-
rabeen, NSW, Australia). The frequencies of cells with arms open
(chromosome arms showed a clear separation), partially open
(chromosome arms were easily distinguishable), and closed (chro-
mosome arms had no separation) were scored. From36 to 53meta-
phase chromosome spreads were counted per cell line.Cell-Cycle Analysis
LCLs in exponential growth were seeded at a density of 1 million
cells per ml. Bromodeoxyuridine (BrdU), an analog of the DNA
precursor thymidine, was added to a final concentration of 10 mM,
and cellswere incubated at 37Cwith 5%CO2. BrdU is incorporated
into newly synthesizedDNA by cells in the S phase of the cell cycle.
After 1 hr incubation in the presence of BrdU, cells were washed
twice in the culture medium so that unincorporated BrdU would
be removed, and they were then cultured in 20 ml fresh medium.
At various time points (0, 6, and 21 hr after BrdU labeling), 5 ml of
cellswere removedandwashed twicewithPBS.Cellswere thenfixed
and processed for BrdU staining and flow cytometry with the BrdU
Flow Kit (BD PharMingen, San Diego, CA, USA) according to the
manufacturer’s instructions. BrdU-positive cells were detected by
FITC-conjugated anti-BrdU antibody in combination with total
DNA content via propidium iodide (PI) staining. Cell-cycle analysis
was performed with FCS Express3 software.8, 2012
Zebrafish Lines
Zebrafish were maintained as described previously.40 Embryos for
experiments were grown at 28C or 22C in E3 medium to the
required developmental stages. All zebrafish research was
approved by the University of Otago Animal Ethics Committee.RNA Synthesis and Microinjection
Capped mRNAs corresponding to the human and zebrafish
RAD21 variants and controls were synthesized with an
SP6 mMessage mMachine transcription kit (Ambion) according
to the manufacturer’s instructions. All mRNAs were resuspended
in water. For microinjection, 400 pg of each mRNA was injected
into the cell of 1 cell embryos from rad21nz171 heterozygous inter-
crosses.
Zebrafish whole-mount in situ hybridization was performed as
described previously.41Statistical Analyses
Statistical analyses of crystal modeling are noted above and in the
Supplemental Data. For mammalian two-hybrid assays and unirra-
diated-basal-DNA-damage comet assays, significance was calcu-
lated with unpaired two-tailed t tests. Analysis of significance for
grouped data sets in the comet assays for sister-chromatid separa-
tion, micronucleus, and DNA-damage recovery was performed by
chi-square analysis. Fisher’s exact test was used for cell-cycle frac-
tion analysis. Analysis of ionizing radiation survival was per-
formed with two-term linear regression. Graphing and statistical
analyses were performed with Prism v. 5.0 (GraphPad Software,
La Jolla, CA) or Stata 11 (StataCorp, College Station, TX). Signifi-
cance values are indicated in the text and figure legends.Results
Identification of Children with Mutations in RAD21
To identify additional potential causal loci for CdLS, we
performed genome-wide array-based copy-number anal-
ysis of 101 individuals with typical CdLS and 189 with
overlapping features. All individuals were negative for
mutations in NIPBL, SMC1A, and SMC3, genes previously
identified as having mutations in CdLS. We identified
a single boy (P1) with a chromosomal alteration contain-
ing a known cohesin gene, specifically, a de novo 8q24.1
interstitial microdeletion that includes RAD21, which
encodes the kleisin subunit that binds to the SMC1 and
SMC3 components of the cohesin complex as well as to
other regulatory proteins, including the STAG/Scc3
proteins1 (Figures 1A and 1B). This boy’s phenotypic
features included synophrys with highly arched eyebrows,
micrognathia, short stature, and minor radial-bone anom-
alies (Figure 1C and Figure S1), but unlike CdLS individuals
with NIPBL, SMC1A, or SMC3 mutations, he displayed
variant features that included sparse temporal scalp hair
and, most remarkably, normal cognitive development.
He was diagnosed as an infant on the basis of his facial
and growth characteristics, which overlapped with those
of CdLS.
To further investigate the effect of 8q24.1 deletions, we
compared the features of two previously reported individ-The Americuals (P242 and P343) and one newly identified individual
(P4) with overlapping deletions. All four children (Figures
1A and 1C) had features consistent with those of other co-
hesin disorders; such features included short stature,
microcephaly, highly arched or thick eyebrows with syn-
ophrys, and palatal and vertebral anomalies. They also dis-
played minor cognitive delays, typically less significant
than those seen in even ‘‘mild’’ CdLS (Figure S1 and Table
S1). Of those genes in the minimal overlapping interval,
RAD21 is the only one known to function in the cohesin
complex, and therefore we hypothesized that it is respon-
sible for this cohesinopathy-like phenotype. Sequencing of
the remaining non-deleted allele for probands P1, P3, and
P4 revealed no additional mutations in RAD21.
Subsequently, we screened the exons of RAD21 for muta-
tions in 258 individuals who had CdLS or overlapping
features and who were previously found to be negative
for mutations in NIPBL, SMC1A, and SMC3. This analysis
identified two additional probands who had atypical clin-
ical features and who demonstrated heterozygous de novo
missense mutations (Figure 1C and Table S1). These chil-
dren (P5 and P6) had c.1127C>G (p.Pro376Arg) and
c.1753T>C (p.Cys585Arg) mutations, respectively. Both
individuals had mild neurodevelopmental deficits and
highly arched eyebrows, although P5 had more substantial
cognitive dysfunction along with a cleft palate, tetralogy of
Fallot, and minor radial head and vertebral anomalies. All
of these features are observed in individuals with muta-
tions in other cohesin genes.44 Importantly, neither of
these mutations was observed in any of the more than
600 control chromosomes from people of European
descent (Table S2).
Expression of RAD21 in Cells Carrying RAD21
Mutations
To understand how these mutations could result in altered
RAD21 activity, we first measured RNA and protein expres-
sion levels from the two available LCLs, one with a contig-
uous gene deletion (P1) and one with the c.1127C>G
(p.Pro376Arg) missense mutation (P5). The cell line with
the RAD21 deletion expressed approximately half the
normal level of RAD21 RNA, but the line with the
c.1127C>G (p.Pro376Arg) mutation expressed a slightly
higher total level of RAD21 RNA, while maintaining
expression of both alleles (Figures S2A an S2B). The
RAD21-deleted cell line also demonstrated reduced protein
levels, whereas the p.Pro376Arg mutation was expressed
at wild-type levels with no altered mobility in immuno-
blotting (Figures S2C and S2D). These data support the
hypotheses that the deletion mutation results in haploin-
sufficiency and that another mechanism of pathogenicity
probably explains the effect of the p.Pro376Arg mutation.
RAD21 Mutations Alter Conserved Amino Acids
To determine whether the RAD21 missense mutations
were pathogenic in these children, we performed a series
of additional analyses. Computational analysis of thean Journal of Human Genetics 90, 1014–1027, June 8, 2012 1017
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Figure 1. Mutations in RAD21
(A) Deletions including RAD21. Localization of deletions (red bars) on 8q24 is indicated by chromosome band and position (hg 18).
Gene locations are indicated in blue with gene names. RAD21 is indicated by a green arrow.
(B) Schematic representation of the cohesin complex. SMC1A (red) and SMC3 (blue) N- (lighter) and C- (darker) termini are indicated.
Relative positions of RAD21 binding to SMC1A via its C terminus and to STAGs via its central region are noted. Black stars indicate rela-
tive positions of missense mutations. A dashed box indicates the region represented in the crystal structure in (D).
(C). Facial features of children with RAD21 mutations. del ¼ RAD21 deletion, P376R ¼ p.Pro376Arg, and C585R ¼ p.Cys585Arg
mutations.
(D) Conservation of RAD21 sequence and position of missense mutations.
(E) Localization of the RAD21 p.Cys585Arg (C585) mutation near the interface with SMC1.
(F) Detail of SMC1 wild-type RAD21 molecular interface.
(G) Modeled effect of RAD21 p.Cys585Arg mutation on SMC1 interaction.
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identified missense mutations demonstrated that the
substituted proline of the p.Pro376Arg mutation is identi-
cally conserved through S. cerevisiae and that the substituted
cysteine of the p.Cys585Argmutation is conserved in verte-
brates (Figure 1D). Furthermore, SIFT45 and Polyphen46
analyses suggest that each of these mutations is likely to be
pathogenic (Table S1). Note that for experiments described
later in thiswork, the conserved residues for thesemutations
in zebrafish are Pro377 and Cys597, as represented in
Figure 1D.
Structural Modeling of the RAD21 p.Cys585Arg
Mutation-SMC1A Complex
We next assessed the potential impact of these mutations
on cohesin structure. To perform its crucial role in regu-
lating sister-chromatid cohesion, RAD21 binds to both
SMC1 and SMC3.1 Specifically, it is thought that the C
terminus of RAD21 initially binds to the C terminus of
SMC1 to incorporate RAD21 into the cohesin ring. This
is followed by interaction of the N terminus with the
SMC3 head domain to close the cohesin ring32
(Figure 1B). To understand the effects of RAD21 mutations
in the structure of the cohesin complex, we modeled the
human SMC1A-RAD21 structure on the basis of available
data from the S. cerevisiae Scc1 cocrystallized with the
Smc1 head domain32 (Figures S3 and S4). Although the
p.Pro376Arg mutation lies outside of this resolved crystal
structure, the p.Cys585Arg mutation is located within
the resolved structure of the C terminus of RAD21 (Figures
1B and 1E–1G) and is positioned near the interface of
RAD21 and the C-terminal amino acids of SMC1
(Figure 1E), suggesting that it might be involved in the
interaction of these two proteins. Additional structural
modeling suggests that the p.Cys585Arg mutation alters
hydrogen bonding of the 585 residue from RAD21
Leu581 to Ser618. This shifts the conformation of the
RAD21 alpha helix that interacts with SMC1 and predicts
decreased hydrogen bonding between the two proteins at
this interface (Figures 1F and 1G and Figures S5 and S6).
In summary, the structural modeling data strongly suggest
altered interactions at the RAD21-SMC1A interface for the
p.Cys585Arg mutation, and such altered interactions
would predict altered functionality of the cohesin
complex. Unfortunately, despite numerous strategies, we
have been unable to model this mutation effectively in
an in vitro assay, and we have no cell line for this girl
and thus cannot assay in vivo interactions.
The p.Pro376Arg Mutation Alters RAD21-STAG
Interaction
In addition to binding to both SMC1 and SMC3,
RAD21 binds to STAG, the fourth core cohesin subunit
(Figure 1B). This interaction is also integral in the regula-
tion of sister-chromatid cohesion.2,47 Importantly, the
p.Pro376Arg mutation resides in a region of conserved
homology (amino acids 372–392) that has been shown
to be essential for interaction of RAD21 with the STAGThe Americproteins.2 Thus, we hypothesized that the p.Pro376Arg
mutation might disrupt RAD21’s interaction with the
STAG proteins.
To test RAD21-STAG interaction in a quantitative
manner, we performed a mammalian two-hybrid assay.
In these experiments, wild-type or mutant human
RAD21 was tested for binding to STAG1, STAG2, or
STAG3. Strikingly, the p.Pro376Arg mutation resulted in
an increased interaction of RAD21 with STAG1 and
STAG2 (120% and 125%, respectively), whereas in that
with STAG3, the meiotic stromalin was unchanged
(Figure 2A). As expected, the p.Cys585Arg mutation that
lies outside the STAG binding region does not alter STAG
binding affinity (Figure 2A).
These data suggest that the RAD21 p.Pro376Arg muta-
tion might interfere with cohesin activity by increasing
the binding of STAG1 and STAG2 to RAD21, an activity
which has been shown to mediate sister-chromatid cohe-
sion along the length of chromosome arms.48 This altered
RAD21-STAG interaction might be predicted to lead to
consequences for sister chromatids in metaphase analyses.
Tighter Sister-Chromosome Cohesion is Observed in
Cells with the p.Pro376Arg Mutation
Because the role of RAD21 has been well described in sister-
chromatid cohesion, and because the above experiments
indicated altered STAG binding, we assessed whether
LCLs from two available probands (P1 [RAD21del] and P5
[p.Pro376Arg]) demonstrated alterations in sister-chro-
matid cohesion. Analysis of metaphase spreads (Figures
2B–2E) showed a substantially higher percentage of sister
chromatids with a closed-arm phenotype in cells with
the p.Pro376Arg mutation (76%) than in controls (5%).
Correspondingly, there was a marked decrease in the
percentage of metaphase spreads showing an open-arm
configuration in p.Pro376Arg (9%) versus control (83%)
LCLs. Additional examination of chromosome numbers
in these LCLs also revealed an increase in aneuploidy;
metaphase spreads demonstrated the gain or loss of one
or more chromosome in 39% (17/44) and 29% (10/34) of
RAD21 p.Pro376Arg and deletion mutant LCLs, respec-
tively. This is in contrast to control cells, where aneuploidy
was observed in7% (3/45) of LCLs. This finding was not
mirrored in DNA obtained from peripheral blood of either
child, as analyzed by genome-wide SNP array under a lower
limit of mosaic aneuploidy detection of ~5%.
Cell-Cycle Progression Is Altered in Cells with the
p.Pro376Arg Mutation
This appearance of closely bound sister chromatids
suggests that these cells might be impeded in their progres-
sion through mitosis. To assess this, we used BrdU to pulse
labeled S-phase cells and monitored their progression
through the cell cycle at 0, 6, and 21 hr time points after
labeling. These analyses of BrdU-positive cells showed
that, 6 hr after the BrdU pulse, there is no effect on progres-
sion from replication to mitosis, and the cell-cycle profilesan Journal of Human Genetics 90, 1014–1027, June 8, 2012 1019
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Figure 2. RAD21 Alteration Effects on the Cohesin Complex
(A) RAD21 p.Pro376Arg increases binding affinity to mitotic STAG proteins. Immunoblotting of similarly expressed hybrid proteins is
indicated below. Significant p values (<0.05) from two-tailed t tests are indicated (*). Open (B), partially open (C) and closed (D) sister-
chromatid phenotypes are demonstrated. (E) Increased prevalence of closed sister chromatids in LCLs from the boy with the
p.Pro376Arg mutation and in normal control LCLs (C1, C2). The RAD21-deleted LCLs (del) show no difference from controls. The
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21 hr after BrdU labeling. The proportion of cells in each cell cycle phase is expressed as the percentage of BrdU-positive cells. Two-sided
Fisher’s exact test is shown. Error bars indicate standard deviations. del ¼ RAD21 deletion, P376R¼ p.Pro376Arg, C585R ¼ p.Cys585Arg
mutations, and CON ¼ control cells.of both the deletion and p.Pro376Arg mutants are similar
to those of control cells; more than 80% are BrdU positive
at the G2/M phase (Figure 2F). However, there appears to
be a delay during mitosis, and by 21 hr after the BrdU
pulse, when the G1 population has progressed to 71% in
control cells and 69% in RAD21-deletion cells, only 49%
of p.Pro376Arg-mutated cells are in G1 (Figure 2F). These
data suggest that increased sister-chromatid cohesin in
the p.Pro376Arg cells does indeed lead to a delay in
progression from the G2/M to G1 phase.1020 The American Journal of Human Genetics 90, 1014–1027, JuneCellular Response to IR Is Compromised by RAD21
Mutations
In addition to its role in sister-chromatid cohesion, RAD21
and its homologs have been shown to play central roles
in mediating IR response and DNA-damage repair in
yeast49,50 and vertebrates.14,51 To determine whether the
mutations we identified resulted in enhanced sensitivity
to IR, a potent inducer of DNA DSBs, we tested the LCLs
in several assays. In a cell-survival assay after IR, we noted
that both RAD21-heterozygote cell lines exhibited8, 2012
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Figure 3. RAD21 Mutations Increase Suscepti-
bility to DNA Damage
(A) Cell survival after a graded dose of ionizing
radiation (IR). Radiation doses are indicated
beneath the samples. Fractional survival was ex-
pressed relative to unirradiated cells. Control
(CON), ATM-mutated (AT), RAD21-deleted (del),
and RAD21 p.Pro376Arg-mutated (P376R) lym-
phoblastoid cell lines are indicated. Each data
point represents the mean of three independent
experiments. Error bars represent SEM.
(B) Representative images of binucleated cells
(BNCs, top left) withmicronuclei (MNi, top right,
arrowheads); nucleoplasmic bridges (NPBs,
bottom left, arrows), and NPBs accompanying
MNi (bottom right panel).
(C) The frequencies of spontaneous and radia-
tion-induced MNi, NPBs, and NPBs accompa-
nying MNi, as shown in (B). The frequencies
were calculated per 200 binucleated cells.
(D) A diagram of the Comet assay, indicating the
head and tail dimensions used for assessments.
(E) The basal level of DNA damage, as measured
by the tail moment in unirradiated cells via the
Comet assay. A significant difference was
observed between the control cell line (CON)
and the RAD21 mutant cell lines. Numbers at
base of column indicate number of nuclei as-
sayed.
(F) DNA damage repair kinetics after IR at 8 Gy.
Cellular DNA damage was measured as the tail
moment and expressed relative to 0 hr after irra-
diation. Also see Figure S7. Significant p values
for p < 0.0001 (***) and p < 0.01 (**) are noted.
del ¼ RAD21 deletion, P376R ¼ p.Pro376Arg,
and C585R ¼ p.Cys585Arg mutations.significantly lower post-IR cell survival than control
cells, but this reduction was not as great as that noted in
cells derived from a homozygous individual with the clas-
sical IR-sensitivity disorder, ataxia telangiectasia52 (AT,
Figure 3A).
It has been shown that, in addition to showing
decreased survival, mouse embryonic fibroblast cell lines
with heterozygous null Rad21mutations exhibit enhanced
chromosomal rearrangements after IR.14 To test whether
the human RAD21 mutant cell lines were similarly
affected, we used a cytokinesis-block micronucleus
assay53 to examine the level of chromosomal damage
induced by IR. In this assay, one can observe binucleated
normal cells (BNCs); micronuclei (MNi), which result
from chromosomal breakage; and nucleoplasmic bridges
(NPBs), which result from chromosomal structural rear-
rangements such as dicentric chromosomes and ring chro-
mosomes (Figure 3B). Our results showed that both RAD21
mutant cell lines exhibited elevated levels of NPBs in unir-
radiated cells, suggesting an increased level of spontaneous
aberrations (Figure 3C, left). After IR, an increase in theThe American Journal of Huoverall number of chromosomal abnormal-
ities was observed in all lines (Figure 3C).
Unlike in control cells, where MNi wereprominent, NPBs and NPBs accompanyingMNi accounted
for the majority of chromosomal aberrations in the two
cell lines with RAD21 mutations (Figure 3C right). These
data suggest that spontaneous and IR-induced chromo-
somal damage in RAD21 mutant cells leads to increased
complex chromosomal aberrations.
To further investigate whether the increased chromo-
somal damage in RAD21mutant cell lines is due to a defect
in DSB repair, we performed a comet assay to evaluate the
kinetics of IR-induced DSB repair in RAD21 mutant and
control LCLs. We determined the tail moment, which
provides an estimate of DNA damage in the form of frag-
mentation (Figure 3D), in both unirradiated and irradiated
cells to assess DNA damage in basal and IR-induced states,
respectively.54 Our results showed that the basal level of
DNA damage, as measured by the tail moment of unirradi-
ated cells, is significantly higher in both RAD21 mutant
cell lines than in the control cell lines (Figure 3E and
Figure S7). To determine the repair kinetics of IR-induced
DNA damage, we compared the tail moments 1 and 4 hr
after IR to those at 0 hr (Figure 3F and Figure S7). In theman Genetics 90, 1014–1027, June 8, 2012 1021
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Figure 4. RAD21 Mutations Alter Tran-
scriptional Activity
Rescue of lateral-plate-mesoderm expres-
sion of runx1 in Rad21-null zebrafish
embryos with zebrafish rad21 mRNA that
are either wild-type (wt zRad21) or carry-
ing the equivalent human mutations (see
Figure 1D).
(A) Wild-type, uninjected 12 somite em-
bryo viewed from the posterior. PLM ¼
posterior lateral-plate mesoderm and
RB ¼ Rohon-Beard cells.
(B) Wild-type embryo with altered runx1
expression.
(C) Rad21 homozygous null embryo with
loss of PLM runx1 expression.
(D and E) Rad21 homozygous null
embryos with full and partial rescues by
mRNA injection.
(F) Genotype fractions of embryos
analyzed for each injection cohort. Red ¼
Rad21-null, blue ¼ wild-type, uninj ¼ un-
injected.
(G) Frequency of altered runx1 expression
in wild-type embryos. Orange ¼ altered
expression and blue ¼ normal expression.
(H) Frequency of runx1 LPM rescue.
Green ¼ full rescue, light green ¼ partial
rescue, and red ¼ no rescue. Error bars
indicate standard deviations. Significant
p values for p < 0.0001 (***) and p < 0.01
(**) are noted.control cell line, approximately 45% of DNA damage re-
mained 1 hr after IR, and by 4 hr after IR only ~10% of
damage remained. In contrast, the p.Pro376Arg mutant
cell line showed significantly slower DNA damage-repair
kinetics; approximately 98% and 53% of residual DNA
damage remained 1 and 4 hr, respectively, after IR. The
RAD21-deletion mutant cell line also showed impaired
repair kinetics, but to a lesser extent; approximately 50%
and 21% of residual DNA damage remained 1 and 4 hr,
respectively, after IR. These results further corroborate an
impaired IR-induced DNA-damage repair in RAD21mutant
cells and, in conjunction with the higher basal-DNA-
damage rate, increased cytogenetic damage, and impaired
repair of that damage, strongly suggest that the RAD21
mutations identified in these individuals result in a suscep-
tibility to the processing of both endogenous and exoge-
nous induced DNA damage.
In summary, these data show that both the RAD21-
deletion and p.Pro376Arg-mutated LCLs are deficient in
their response to IR, as manifested by decreased survival
and increased chromosomal rearrangements and DSBs.
Furthermore, the p.Pro376Arg mutation causes deficient
repair of cellular DNA damage. These observations all
support the hypothesis that these mutations disrupt
RAD21 function.
RAD21 Mutations Alter Transcription in a Zebrafish
Model
Significant evidence has demonstrated that, in addition to
functioning in sister-chromatid cohesion and DNA1022 The American Journal of Human Genetics 90, 1014–1027, Junestability, the cohesin complex plays a key role in transcrip-
tional regulation.5,6,8,9,55–57 One of the best examples of
this activity has been observed in zebrafish, where Rad21
is required for transcription of runx1 in the posterior lateral
platemesoderm (PLM) and for the transcription of runx3 in
neuronal tissues.8 runx1 is required for both hematopoietic
and neuronal cell development (Figure 4A). Remarkably,
expression of runx1 is absent in the PLM of mutants
carrying homozygous rad21nz171-null alleles, whereas
normal expression is retained in neuronal cells from the
4–15 somite stage (11–15 hr post-fertilization [hpf]), indi-
cating a tissue-specific effect of Rad21 loss on runx1 expres-
sion8 (Figure 4C and Table S3). Expression of runx1 could
be rescued bymicroinjection of either human RAD21 or ze-
brafish rad21mRNA into rad21-null embryos8 (Figure 4D),
whereas a transcript containing the rad21nz171-null muta-
tion did not rescue expression (Tables S3 and S4). There-
fore, we used the biological readout of rescued runx
gene-expression pattern in zebrafish rad21 mutants to
determine whether the identified human RAD21 muta-
tions are competent to facilitate transcription.
Because the wild-type human RAD21 mRNAs were
moderately toxic to developing zebrafish embryos, the
missense mutations were introduced into the equivalent
positions of the zebrafish Rad21 (see Figure 1D), and in-
vitro-transcribed mRNA encoding each of these mutations
was injected into 1 cell zebrafish embryos. The distribution
of runx1 or runx3 transcripts was examined at the 10–12
somite stage. After being scored, embryos were genotyped
for the rad21nz171-null allele.8, 2012
Zebrafish p.Pro377Arg rescued expression of runx1 in
65% of rad21-null zebrafish embryos (Figures 4D and 4H;
Table S3). However, this variant also caused altered tran-
scription in wild-type embryos. It resulted in ~50% more
atypical runx1 expression than wild-type Rad21 (Figures
4B and 4G). Remarkably, the human p.Pro376Arg RAD21
mutation altered spatiotemporal expression of runx1 in
nearly all surviving embryos, suggesting that the human
p.Pro376Arg protein has additional activity when
compared with wild-type RAD21. Analysis of runx3 expres-
sion yielded similar results (Table S4). These data reflect the
greater disruption of normal features in the boy carrying
the RAD21 p.Pro376Arg mutation.
In contrast, the zebrafish p.Cys597Arg Rad21 mutation
failed to rescue runx1 expression in rad21-null embryos
and exhibited only background levels of activity in wild-
type embryos. Analysis of runx3 expression yielded
similar results (Table S4), and the activity of the zebrafish
p.Cys597Arg mutation was equivalent to that of the
rad21nz171-null mRNA, which contains a nonsense muta-
tion and does not produce Rad21 protein.8 Furthermore,
these data are consistent with the compromised human
p.Cys585Arg RAD21 function predicted by the structural
analysis and with the clinical features of the boy carrying
this mutation, who demonstrates mild features similar to
those of the patients with deletion alleles.Discussion
Using a strategy of genome-wide copy-number analysis of
individuals with presumed CdLS, we identified a single
proband with a de novo deletion of 8q24.1 that includes
RAD21. We subsequently assessed three additional
individuals with deletions that include RAD21 and identi-
fied two with de novo missense mutations in RAD21
(Figure 1, Figure S1, and Table S1). Quite remarkably,
although these children have some overlap with CdLS,
they clearly have some divergence in the facial features
and, most notably, have extremely mild cognitive and
physical abnormalities. Common features in these
patients include short stature, synophrys, micrognathia,
brachydactyly, mild radioulnar differences, vertebral
anomalies, and very mild cognitive involvement. The
boy with the p.Pro376Arg mutation has more severe
features, including mild mental retardation, tetralogy of
Fallot, and hearing loss.
Of note, RAD21 lies between TRPS1 (MIM 604386) and
EXT1 (MIM 608177) and would be deleted in persons
with the Langer-Giedion/Trichorhinophalangeal syn-
drome, type II (TRPS II [MIM 150230]) deletion.58 It is
likely that the mild facial and cognitive involvement
seen in these individuals with RAD21 heterozygous loss-
of-function mutations causes many individuals to go clin-
ically unnoticed, and in the context of TRPS II, these
features would be overshadowed by the distinctive facial
and hand features caused by disruption of TRPS1.59The AmericTo confirm the pathogenicity of individual RAD21muta-
tions, we employed a number of assessments of RAD21
function. In silico analyses revealed conservation of iden-
tity of the mutated residues in vertebrate lineages, and
they revealed conservation of the p.Pro376Arg mutation
through yeast (Figure 1D). Structural modeling suggests
that the p.Cys585Arg mutation would cause significant
alterations in hydrogen bonding and thus disrupt the
RAD21/SMC1 interface (Figures 1F and 1G). Because the
SMC1-RAD21 interaction probably initiates RAD21 incor-
poration into the SMC1/SMC3 complex,32 disruption of
this interaction would probably cause a defect in forma-
tion of functional cohesin complexes. Efforts to obtain
a functional readout of the interaction between the
RAD21 p.Cys585Arg mutation and SMC1A via two-hybrid
or coimmunoprecipitation assays of overexpressed or
tagged proteins (data not shown) were unfortunately
unsuccessful. Furthermore, it is not possible to assess this
interaction in vivo with endogenous proteins because
a cell line for this girl is unavailable.
Because the RAD21 p.Pro376Arg mutation resides in the
amino acid domain that interacts with the STAG proteins,2
we tested the interaction of STAG1, -2, and -3 with wild-
type and mutant RAD21. As expected, the p.Cys585Arg
mutation, which resides outside the interaction region,
does not affect RAD21-STAG binding. Strikingly, the
p.Pro376Arg mutation increases binding to both STAG1
and STAG2 (Figure 2A). This suggests that pathology asso-
ciated with p.Pro376Arg could be due to retained asso-
ciation of RAD21 with STAG through anaphase;60 such
retained association could lead to illegitimate sister-
chromosome interactions, such as the increased nucleo-
plasmic bridging that we noted in our cytokinesis block
assays (Figures 3B and 3C). Alternatively, it could result
from reduced dissociation of the cohesin complex from
STAG1 and -2 in prophase,60 causing delayed sister-
chromatid separation or altered transcription.10 Finally,
tighter association of RAD21 with STAG could cause cohe-
sin to be resistant to removal by theWAPAL/PDS5 complex
in interphase cells. This would lead to longer cohesin
residency times on chromosomes and in turn lead to
disregulation of genes normally controlled by cohesin.
Cued by the structural data and previous work demon-
strating that alterations in the cohesin complex disrupt
transcription,6–8 we used the rescue of rad21-null zebra-
fish embryos, which lack expression of runx1 and runx3,
as a biological readout for transcriptional competency
of RAD21 mutations. Unlike wild-type Rad21, the
p.Cys585Arg/zebrafish p.Cys597Arg mutation had little
ability to rescue runx gene expression, confirming a loss of
function for this mutation. In contrast, the p.Pro376Arg/
zebrafish p.Pro377Arg mutation was able to partially
rescue runx1/3 expression in rad21-null fish, but it also
surprisingly affected expression in wild-type embryos,
suggesting an altered activity rather than a loss of func-
tion. Inappropriate activation of runx1 expression in
zebrafish embryos expressing the p.Pro376Arg mutationan Journal of Human Genetics 90, 1014–1027, June 8, 2012 1023
is consistent with structural data indicating tighter
binding to STAG.
To test whether the RAD21 mutations altered sister-
chromatid cohesion,61 we assessed sister-chromatid sepa-
ration in metaphase spreads of lymphoblastoid cells,
which demonstrated decreased separation in those carry-
ing the p.Pro376Arg mutation. These data are consistent
with the increased binding of the p.Pro376Arg mutant
protein to STAG and suggest that this binding might be
improperly retained, resulting in tighter binding of sister
chromatids as a result of the improper removal of cohesin
via the prophase pathway of cohesin dissociation.60,62
Because RAD21 is involved in radiation damage response
and DNA repair,12,14,50,63–65 we assessed the radiation
sensitivity of LCLs from the individuals with RAD21-
deletion and p.Pro376Arg mutations. These cell lines
demonstrated an increased IR sensitivity, resulting in
reduced survival and increased chromosomal aberrations
(Figure 3). Further analysis revealed that RAD21 mutant
cells showed slower DNA DSB repair, suggesting that a defi-
ciency in DSB repair is probably the underlying cause of
enhanced cellular IR sensitivity and chromosomal aberra-
tions in RAD21 mutant cells. Enhanced cellular sensitivity
to IR has also been observed in CdLS cell lines with NIPBL,
SMC1A, and SMC3mutations, concordant with the RAD21
mutations and consistent with the idea that cellular hyper-
sensitivity to DNA-damaging agents might be a general
feature of CdLS.11,65 These data are consistent with this
notion.
Although short-term radiation sensitivity is elevated in
cells derived from individuals with CdLS, the clinical
implications of such findings are less clear. RAD21 variants
were found in radiosensitive (RS) cancer patients, sug-
gesting altered RAD21 function associates with radiation
sensitivity.66 Additionally, Rad21 heterozygous mice
demonstrated global enhancement of radiosensitivity after
whole-body irradiation.14 Our findings of cellular radio-
sensitivity in cells with the heterozygous RAD21-deletion
mutation (P1) and the p.Pro376Arg mutation (P5) raises
the possibility that these individuals might sustain greater
than expected side effects upon exposure to DNA-
damaging agents such as radiotherapy. Significantly, no
tumors or malignancies have been noted in these children,
nor in other people with CdLS.67,68 Although cells from
patients with many human radiation-sensitivity syn-
dromes, such as ataxia telangiectasia (AT [MIM 208900]),
Nijmegen breakage syndrome, (NBS [MIM 251260]), and
ataxia-telangiectasia-like disorder (ATLD [MIM 604391]),
have genomic instability and the individuals are prone to
cancer, these two features do not invariably coassociate.
For example, individuals with trichothiodystrophy (TTDP
[MIM 601675]) and Cockayne syndrome (MIM 216400)
display elevated radiation sensitivity but no apparent
cancer predisposition. It is also possible that defects in
cohesin protect individuals from cancer given that MYC
is often downregulated when there is a loss of cohesin
function.691024 The American Journal of Human Genetics 90, 1014–1027, JuneOverall, this combination of phenotypic, molecular, and
cellular data emphasizes a role for RAD21 mutations as
a cause of a human congenital disorder. Although only
six individuals have been studied in this work, we would
speculate that the extremely mild nature of this cohesin-
opathy leads to underascertainment. Thus, we would
expect that in the coming years, with the advent of
whole-exome and -genome sequencing for clinical diag-
nosis, additional persons will be identified.Supplemental Data
Supplemental Data include seven figures and five tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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